biospecimen_aliquot__bcr_aliquot_barcode	tcga-ac-a3od-01b-06d-a22n-09
biospecimen_aliquot__bcr_aliquot_uuid	be2289c3-491b-4571-b79a-6dbee48e172c
biospecimen_aliquot__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_aliquot__bcr_sample_barcode	tcga-ac-a3od-01b
biospecimen_aliquot__biospecimen_barcode_bottom	0118967866
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2012-05-30
biospecimen_aliquot__is_derived_from_ffpe	yes
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a22n
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ac-a3od-01b-06d
biospecimen_analyte__bcr_analyte_uuid	bd9f70e1-c147-4642-af15-2e2063ef2a55
biospecimen_analyte__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_analyte__bcr_sample_barcode	tcga-ac-a3od-01b
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	yes
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_normal_control__bcr_patient_barcode	tcga-ac-a3od
biospecimen_normal_control__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_portion__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_portion__bcr_portion_barcode	tcga-ac-a3od-01b-06
biospecimen_portion__bcr_portion_uuid	0b5f179a-292b-4618-b3fe-b26067407a6b
biospecimen_portion__bcr_sample_barcode	tcga-ac-a3od-01b
biospecimen_portion__date_of_creation	2012-05-16
biospecimen_portion__is_ffpe	yes
biospecimen_portion__portion_number	06
biospecimen_portion__portion_sequence	6
biospecimen_portion__weight	400.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ac-a3od-01b-06d
biospecimen_protocol__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_protocol__bcr_sample_barcode	tcga-ac-a3od-01b
biospecimen_protocol__experimental_protocol_type	allprep ffpe dna
biospecimen_sample__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_sample__bcr_sample_barcode	tcga-ac-a3od-01b
biospecimen_sample__bcr_sample_uuid	18140097-dcf9-4882-baa9-5f6c93585c4b
biospecimen_sample__days_to_collection	161
biospecimen_sample__is_ffpe	yes
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-ac-a3od.9f7e2b98-29e7-465f-ae12-33d78fdfd71a.pdf
biospecimen_sample__pathology_report_uuid	9f7e2b98-29e7-465f-ae12-33d78fdfd71a
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	b
biospecimen_slide__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
biospecimen_slide__bcr_sample_barcode	tcga-ac-a3od-01b
biospecimen_slide__bcr_slide_barcode	tcga-ac-a3od-01b-05-bs5
biospecimen_slide__bcr_slide_uuid	3f8c2493-c6d0-45f1-9347-8d1d92d66e4e
biospecimen_slide__image_file_name	tcga-ac-a3od-01b-05-bs5.3f8c2493-c6d0-45f1-9347-8d1d92d66e4e.svs
biospecimen_slide__is_derived_from_ffpe	yes
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	5
biospecimen_slide__percent_stromal_cells	35
biospecimen_slide__percent_tumor_cells	60
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ac-a3od
biospecimen_tumor_sample__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
clinical_follow_up__bcr_followup_barcode	tcga-ac-a3od-f45582
clinical_follow_up__bcr_followup_uuid	1c298e20-d286-4a08-9193-1ab7f91cc8bd
clinical_follow_up__bcr_patient_barcode	tcga-ac-a3od
clinical_follow_up__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-7-17
clinical_follow_up__last_contact_days_to	451
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	68
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n1mi
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ac-a3od
clinical_patient__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
clinical_patient__birth_days_to	-25186
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2012-4-19
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	35
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	3
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a3od
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	90-99%
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ac
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ac-a3od
clinical_radiation__bcr_patient_uuid	f2622cdb-ac92-42b3-a1ca-67e133c3dd4a
clinical_radiation__bcr_radiation_barcode	tcga-ac-a3od-r45583
clinical_radiation__bcr_radiation_uuid	976c8875-ac78-48c4-ad55-5dfcb541e560
clinical_radiation__form_completion_date	2013-7-17
clinical_radiation__radiation_adjuvant_fractions_total	25
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	120
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	76
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	6040
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A3OD-01B-06D-A22N-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A3OD-01B-06D-A22N-09.bed.meta
manually_curated__id	tcga-ac-a3od-01b-06d-a22n-09
manually_curated__md5sum	3ffa32ce8c00a13f204635b6f49454c4
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	be2289c3-491b-4571-b79a-6dbee48e172c
manually_curated__tumor_tag	brca
